AI Article Synopsis
- The study aimed to evaluate the effectiveness of "Benovoair Concentrate" against influenza viruses A and B.
- Researchers mixed various dilutions of the concentrate with the influenza virus and observed the results in cultured cells at 37 degrees Celsius.
- Results showed that specific dilutions (1:60, 1:120, 1:240, and 1:480) displayed 100% effectiveness against both types of viruses, while higher dilutions (1:960 and 1:1920) showed reduced effectiveness (25%-50%).
Article Abstract
Objective: Anti-influenza virus activity of "Benovoair Concentrate".
Methods: The different dilution of samples were mixed with the same quantity of 100 TCID50 virus at 37 degrees C for 30 minutes. Add suitable quantity mixture in wells containing cells. Every 3 wells were the same mode. Viruses control, cells control and samples control of different dilution were performed and set in the CO2 incubator at 37 degrees C. CPE was observed every day. When CPE appears in viruses control as "++++", stopped testing and performed the hemagglutination titration.
Results: "Benovoair Concentrate" with dilution of 1:60, 1:120, 1:240 and 1:480 have 100% anti-influenza A and anti-influenza B activities. "Benovoair Concentrate" with dilution of 1:960 and 1:1920 have 25%-50% anti-influenza A and anti-influenza B activities.
Conclusion: The test was the proof of anti-influenza virus activities which provided for the development of "Benovoair Concentrate".
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!